After Principal Investigator and Department Chair sign-off is complete, the next step in the protocol application submission process is the review of the application by the Human Research Office (HRO) and scheduling of an IRB board meeting. The HRO determines the type of IRB review necessary to reach approval. Depending upon the level of risk and procedures involved in the research, the protocol will be reviewed either at a convened meeting of the IRB (Full Board Review) or by a single IRB Chairperson or designee (Expedited Review).
Note: Certain protocols may require additional review by other Ancillary committees (i.e. Pharmacy, Biomedical Engineering, Radiation) depending on the nature of the study and the procedures involved.
Screenshot: Human Research Office Review
Click on the link in the “Type” or the “Action Required” column: